// App-Quantinova.ai

Mo1930 : ATM and P53 Expression Level Correlate With Sensitivity to Olaparib in Gastric Cancer

Researchers

Presenter

  • Chris T. Williamson

Principal Investigators

  • Susan P. Lees-Miller

  • Gwyn Bebb

Medical Centers

  • Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan

  • Biochemistry and Molecular biology, University of Calgary, Calgary, Alberta, Canada

  • Institute for Cancer Research, London, United Kingdom

  • Department of Surgery, University of Calgary, Calgary, AB, Canada

Locations

  • Canada

  • Japan

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Ataxia telangiectasia

  • Mantle cell lymphoma

  • Gastric Cancer

  • Breast cancer

  • Lymphomas

  • Solid malignancies

  • Seizures sensorineural deafness ataxia mental retardation electrolyte imbalance

Biomarkers

  • Breast cancer type 1 susceptibility protein

  • Jagged canonical Notch ligand 1

Drug/Treatment

  • Olaparib

  • KU-55933

  • ribose

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved